61. Patient-Reported Out-of-Pocket Costs and Financial Toxicity During Early-Phase Oncology Clinical Trials. (21st April 2021) Authors: Huey, Ryan W.; George, Goldy C.; Phillips, Penny; White, Revenda; Fu, Siqing; Janku, Filip; Karp, Daniel D.; Naing, Aung; Piha-Paul, Sarina; Subbiah, Vivek; Tsimberidou, Apostolia M.; Pant, Shubham; Yap, Timothy A.; Rodon, Jordi; Meric-Bernstam, Funda; Shih, Ya-Chen Tina; Hong, David S. Journal: Oncologist Issue: Volume 26:Number 7(2021) Page Start: 588 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
62. Patient-Reported Outcomes with Selpercatinib Among Patients with RET Fusion–Positive Non-Small Cell Lung Cancer in the Phase I/II LIBRETTO-001 Trial. (30th September 2021) Authors: Minchom, Anna; Tan, Aaron C; Massarelli, Erminia; Subbiah, Vivek; Boni, Valentina; Robinson, Bruce; Wirth, Lori J; Hess, Lisa M; Jen, Min-Hua; Kherani, Jennifer; Olek, Elizabeth; McCoach, Caroline E Journal: Oncologist Issue: Volume 27:Number 1(2022) Page Start: 22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
63. Patient-Reported Outcomes with Selpercatinib Treatment Among Patients with RET-Mutant Medullary Thyroid Cancer in the Phase I/II LIBRETTO-001 Trial. (30th September 2021) Authors: Wirth, Lori J; Robinson, Bruce; Boni, Valentina; Tan, Daniel S W; McCoach, Caroline; Massarelli, Erminia; Hess, Lisa M; Jen, Min-Hua; Kherani, Jennifer; Olek, Elizabeth; Subbiah, Vivek Journal: Oncologist Issue: Volume 27:Number 1(2022) Page Start: 13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
64. Patient‐Reported Out‐of‐Pocket Costs and Financial Toxicity During Early‐Phase Oncology Clinical Trials. (21st April 2021) Authors: Huey, Ryan W.; George, Goldy C.; Phillips, Penny; White, Revenda; Fu, Siqing; Janku, Filip; Karp, Daniel D.; Naing, Aung; Piha‐Paul, Sarina; Subbiah, Vivek; Tsimberidou, Apostolia M.; Pant, Shubham; Yap, Timothy A.; Rodon, Jordi; Meric‐Bernstam, Funda; Shih, Ya‐Chen Tina; Hong, David S. Journal: Oncologist Issue: Volume 26:Number 7(2021) Page Start: 588 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
65. Pembrolizumab in Patients with Advanced Metastatic Germ Cell Tumors. (12th February 2021) Authors: Tsimberidou, Apostolia-Maria; Vo, Henry Hiep; Subbiah, Vivek; Janku, Filip; Piha-Paul, Sarina; Yilmaz, Bulent; Gong, Jing; Naqvi, Mohammad Faraz; Tu, Shi-Ming; Campbell, Matthew; Meric-Bernstam, Funda; Naing, Aung Journal: Oncologist Issue: Volume 26:Number 7(2021) Page Start: 558 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
66. Pembrolizumab in Patients with Advanced Metastatic Germ Cell Tumors. (12th February 2021) Authors: Tsimberidou, Apostolia‐Maria; Vo, Henry Hiep; Subbiah, Vivek; Janku, Filip; Piha‐Paul, Sarina; Yilmaz, Bulent; Gong, Jing; Naqvi, Mohammad Faraz; Tu, Shi‐Ming; Campbell, Matthew; Meric‐Bernstam, Funda; Naing, Aung Journal: Oncologist Issue: Volume 26:Number 7(2021) Page Start: 558 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
67. Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients with BRAF‐mutated melanoma and other advanced malignancies. Issue 3 (1st November 2018) Authors: Bhatty, Minny; Kato, Shumei; Piha‐Paul, Sarina A.; Naing, Aung; Subbiah, Vivek; Huang, Helen J.; Karp, Daniel D.; Tsimberidou, Apostolia M.; Zinner, Ralph G.; Hwu, Wen‐Jen; Javle, Milind; Patel, Sapna P.; Hu, Mimi I.; Varadhachary, Gauri R.; Conley, Anthony P.; Ramzanali, Nishma M.; Holley, Veron... Journal: Cancer Issue: Volume 125:Issue 3(2019) Page Start: 463 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
68. Phase 2 study of pembrolizumab in patients with advanced rare cancers. Issue 1 (17th March 2020) Authors: Naing, Aung; Meric-Bernstam, Funda; Stephen, Bettzy; Karp, Daniel D; Hajjar, Joud; Rodon Ahnert, Jordi; Piha-Paul, Sarina A; Colen, Rivka R; Jimenez, Camilo; Raghav, Kanwal P; Ferrarotto, Renata; Tu, Shi-Ming; Campbell, Matthew; Wang, Linghua; Sabir, Sarjeel H; Tapia, Coya; Bernatchez, Chantale; ... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
69. Phase I clinical trial of combination imatinib and ipilimumab in patients with advanced malignancies. Issue 1 (18th April 2017) Authors: Reilley, Matthew J.; Bailey, Ann; Subbiah, Vivek; Janku, Filip; Naing, Aung; Falchook, Gerald; Karp, Daniel; Piha-Paul, Sarina; Tsimberidou, Apostolia; Fu, Siqing; Lim, JoAnn; Bean, Stacie; Bass, Allison; Montez, Sandra; Vence, Luis; Sharma, Padmanee; Allison, James; Meric-Bernstam, Funda; Hong, ... Journal: Journal for immunotherapy of cancer Issue: Volume 5:Issue 1(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
70. Phase I study of ABBV-428, a mesothelin-CD40 bispecific, in patients with advanced solid tumors. Issue 2 (19th February 2021) Authors: Luke, Jason J; Barlesi, Fabrice; Chung, Ki; Tolcher, Anthony W; Kelly, Karen; Hollebecque, Antoine; Le Tourneau, Christophe; Subbiah, Vivek; Tsai, Frank; Kao, Steven; Cassier, Philippe A; Khasraw, Mustafa; Kindler, Hedy L; Fang, Hua; Fan, Frances; Allaire, Kathryn; Patel, Maulik; Ye, Shiming; Cha... Journal: Journal for immunotherapy of cancer Issue: Volume 9:Issue 2(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗